MARGARET GOODELL to Molecular Targeted Therapy
This is a "connection" page, showing publications MARGARET GOODELL has written about Molecular Targeted Therapy.
Connection Strength
0.582
-
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia. Blood. 2016 08 18; 128(7):971-81.
Score: 0.448
-
New insights into the biology of acute myeloid leukemia with mutated NPM1. Int J Hematol. 2019 Aug; 110(2):150-160.
Score: 0.134